Private Capital's ABBV Position Overview
Private Capital (via Private Capital Management, LLC) currently holds 1.5K shares of AbbVie Inc. (ABBV) worth $345,184, representing 0.03% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Private Capital has maintained a strategic position in ABBV, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 187 shares. Largest reduction occurred in Q1 2024, reducing 187 shares.
Analysis based on 13F filings available since 2013 Q2
Private Capital's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Private Capital
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +1,606 | New Buy | 1,606 | $134.73 |
| Q4 2023 | +187 | Add 11.64% | 1,793 | $154.99 |
| Q1 2024 | -187 | Reduce 10.43% | 1,606 | $182.15 |
| Q2 2024 | -99 | Reduce 6.16% | 1,507 | $171.47 |
| Q2 2025 | -16 | Reduce 1.06% | 1,491 | $185.60 |
Private Capital's AbbVie Investment FAQs
Private Capital first purchased AbbVie Inc. (ABBV) in Q2 2023, acquiring 1,606 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital has held AbbVie Inc. (ABBV) for 10 quarters since Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital's largest addition to AbbVie Inc. (ABBV) was in Q2 2023, adding 1,606 shares worth $216,372. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Private Capital's firm, Private Capital Management, LLC, owns 1,491 shares of AbbVie Inc. (ABBV), valued at approximately $345,184. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.03% of Private Capital's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital's peak holding in AbbVie Inc. (ABBV) was 1,793 shares, as reported at the end of Q4 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.